share_log

One Bio Secures $27 Million in Series A Funding to Revolutionize Nutrition With Launch of Breakthrough Technology Making High-Dose, Anti-Inflammatory Plant Fiber Imperceptible in Food and Beverage for the First Time

One Bio Secures $27 Million in Series A Funding to Revolutionize Nutrition With Launch of Breakthrough Technology Making High-Dose, Anti-Inflammatory Plant Fiber Imperceptible in Food and Beverage for the First Time

One Bio獲得2700萬美元A輪融資,革命性地推出突破性科技,使高劑量抗炎植物纖維首次在食品和飲料中變得不可察覺。
PR Newswire ·  12/14 04:28

New funding goes to groundbreaking products that pour plant fibers into our favorite foods to reduce the toxic impact of sugar and lower the incidence of metabolic disorders linked to the modern processed diet

新的資金用於開創性的產品,這些產品將植物纖維添加到我們喜愛的食品中,以減少糖的毒性影響,並降低與現代加工飲食相關的代謝疾病發生率。

SACRAMENTO, Calif., Dec. 13, 2024 /PRNewswire/ -- One Bio, a pioneering biotechnology company committed to revolutionizing nutrition to empower people to live better, longer, has raised $27 million in Series A funding led by Alpha Edison and joined by new investors including Leaps by Bayer, Mitsui E12, Morado, ReMY, DSM-Ferminich, and Better – alongside existing investors including iSelect, Skyview Life Sciences, Collaborative and Acre. This catalytic investment round energized a unique global mix of strategic and institutional investors and is a testament to investor belief in One Bio's potential to reshape how much (and how often) the world consumes fiber, and to combat the disease epidemic linked to the modern processed diet by transforming your favorite foods into engines of good health while helping all of us reduce and eliminate the harm of sugar.

加利福尼亞州薩克拉門託,2024年12月13日 /PRNewswire/ -- One Bio是一家開創性的生物技術公司,致力於改革營養,使人們能夠改善生活質量並延長壽命,已獲得由Alpha Edison主導的2700萬美元A輪融資,新投資者包括Bayer的Leaps、三井E12、Morado、ReMY、DSM-Ferminich和Better,以及現有投資者iSelect、Skyview生命科學、Collab和Acre。此輪催化性投資吸引了一批獨特的全球戰略和機構投資者,證明了投資者對One Bio能夠重塑全球纖維消費方式的潛力的信心,並通過將我們喜愛的食品轉變爲健康的引擎來應對與現代加工飲食相關的疾病流行,同時幫助我們所有人減少和消除糖的危害。

One Bio has innovated a technological process that releases anti-inflammatory short chain fibers from thousands of plants, making them undetectable, more bioactive and uniquely high dose. This novel process unlocks fibers from seeds, nuts, fruits, vegetables, legumes and grains.

One Bio創新了一種技術過程,從數千種植物中釋放抗炎短鏈纖維,使其不可檢測,更具生物活性且劑量獨特。這一新穎的過程從種子、堅果、水果、蔬菜、豆類和穀物中解鎖纖維。

People today consume 10X more sugar than they did 200 years ago and 90% less fiber than we evolved to. Consequently, 95% of people are running a dramatic fiber deficiency that starves the microbiome while denying our bodies of core functions for healthspan. The result is skyrocketing rates of inflammatory disease including obesity, diabetes, cardiovascular, neurodegenerative, cancer and autoimmunity. One Bio promises a meaningfully positive shift in these alarming public health outcomes by not only eliminating traditional barriers to fiber consumption - like taste, texture, and appearance - but also reframing naturally-derived fiber as an essential but *undetectable* ingredient in our favorite foods and beverages.

如今,人們攝入的糖是200年前的10倍,而纖維的攝入量卻比我們進化以來少了90%。因此,95%的人面臨嚴重的纖維缺乏症,這使腸道微生物群遭受飢餓,同時剝奪我們身體維持健康所需的核心功能。結果是炎症疾病,包括肥胖、糖尿病、心血管疾病、神經退行性疾病、癌症和自身免疫性疾病的發病率飆升。One Bio承諾通過消除傳統纖維攝入的障礙 - 如口味、質地和外觀 - 並將天然獲得的纖維重新框架爲我們喜愛的食品和飲料中一種必不可少但*不可檢測*的成分,帶來這些令人擔憂的公共衛生結果的顯著積極變化。

As humans evolved, our beneficial gut microbes co-evolved to unlock and consume the sugars bound in the rich diversity of fibers present in plant foods to produce molecules we need to provide core functions including balancing our blood glucose, regulating mood & energy, and making us feel satiated. But modern diets composed of processed foods have isolated the sugars and discarded the fibers. One Bio short chain fibers can even provide an offramp to reduce the population's reliance on GLP-1s to treat chronic metabolic diseases: increasing consumption of high-fiber foods can prevent such diseases in the first place.

隨着人類的進化,我們有益的腸道微生物共同進化,以解鎖並攝取植物食品中豐富多樣的纖維所含的糖分,從而產生我們需要的分子,以提供核心功能,包括平衡我們的血糖、調節情緒和能源,以及讓我們感到飽腹。但現代以加工食品爲主的飲食孤立了糖分並丟棄了纖維。生物短鏈纖維甚至可以爲減少人們對GLP-1治療慢性代謝疾病的依賴提供一個替代方案:增加高纖維食品的消費可以從根本上預防這些疾病。

"Modern food processing techniques strip plant fibers from our foods and starve the microbiome of the nutrients it needs to make us healthy. One Bio works to help us restore core functionality to our diet like blood glucose regulation and mood & energy balance. We aim to avoid and reverse the negative impact of today's processed food diet which accounts for 70% of calories consumed. We have the opportunity to offer industry and people an exponentially better set of choices than those on shelves today," said Matt Barnard, Co-founder and CEO of One Bio. "One Bio puts thriving microbiomes to work delivering longevity, aiding digestion and providing the fuel we need to maximize health," he added.

「現代食品加工技術剝離了我們食物中的植物纖維,使微生物群失去了保持我們健康所需的營養。 One Bio致力於幫助我們恢復飲食的核心功能,比如血糖調節和情緒與能量平衡。我們的目標是避免和逆轉當今加工食品飲食的負面影響,該飲食佔據了70%的熱量消費。我們有機會爲行業和人們提供一系列選擇,遠遠優於今天貨架上的產品。」 One Bio的聯合創始人兼首席執行官Matt Barnard說。「One Bio利用繁榮的微生物群來增強長壽、幫助消化並提供我們所需的能量,以最大化健康。」他補充道。

"Faced with endless shelves of processed and packaged foods, and surrounded by chronic diseases, consumers are rapidly awakening to the power of the gut microbiome. An avalanche of signals points to a large pool of latent demand. This is One Bio's market," added Nate Redmond of Alpha Edison. "One Bio enables their partners to deliver functional products that reshape global health and unlock growth. We are thrilled to be working with Matt and the talented, passionate leaders who are building a category leading platform company.

「面對無盡的加工和包裝食品貨架,周圍充斥着慢性疾病,消費者們迅速覺醒於腸道微生物組的力量。大量的信號指向一個潛在需求的大池。這就是One Bio的市場。」 Alpha Edison的Nate Redmond補充道。「One Bio使他們的合作伙伴能夠提供功能性產品,重塑全球健康並解鎖增長。我們非常高興能與Matt以及建立領先類別平台公司的才華橫溢、充滿熱情的領導者們合作。」

For more information about One Bio, please visit one.bio.

有關One Bio的更多信息,請訪問 one.bio.

About One Bio:
One Bio is a biotechnology company returning healthspan to our diet by reintroducing active plant fibers to our food and reshaping how we approach health and nutrition in everyday products. Using their cutting-edge technology, One Bio has demonstrated its ability to solve malnutrition in the modern diet. The company specializes in releasing short chain fibers from plants, while making them easily consumable and highly effective to invigorate our microbiome and immune system. Through its innovative solutions and strategic partnerships, One Bio aims to eradicate inflammatory disease and help people thrive.

關於One Bio:
One Bio 是一家生物技術公司,通過將活性植物纖維重新引入我們的飲食,恢復健康壽命,並重塑我們在日常產品中對健康和營養的看法。利用其尖端科技,One Bio已證明其能夠解決現代飲食中的營養不良。該公司專注於從植物中釋放短鏈纖維,同時使其易於食用且能有效振興我們的微生物組和免疫系統。通過其創新解決方案和戰略合作伙伴關係,One Bio旨在消除炎症疾病,幫助人們蓬勃發展。

Press contact:
Original Strategies
Simone Hassan-Bey
[email protected]

媒體聯繫人:
原始策略
西蒙·哈桑-貝伊
[email protected]

SOURCE One Bio

來源 One Bio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想讓貴公司的資訊在PRNEWSWIRE.COM上特色展示嗎?

440k+
440k+

Newsrooms &
新聞編輯室和

Influencers
意見領袖
9k+
9k+

Digital Media
數字媒體

Outlets
Outlets
270k+
270k+

Journalists
記者

Opted In
已選擇加入
GET STARTED
開始

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論